These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25890480)

  • 1. Combined cellular immunotherapy and chemotherapy improves clinical outcome in patients with gastric carcinoma.
    Cui J; Li L; Wang C; Jin H; Yao C; Wang Y; Li D; Tian H; Niu C; Wang G; Han W; Xu J; Chen J; Li W
    Cytotherapy; 2015 Jul; 17(7):979-88. PubMed ID: 25890480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant treatment combining cellular immunotherapy with chemotherapy improves the clinical outcome of patients with stage II/III gastric cancer.
    Wang Y; Wang C; Xiao H; Niu C; Wu H; Jin H; Yao C; He H; Tian H; Han F; Li D; Han W; Xu J; Chen J; Cui J; Li W
    Cancer Med; 2017 Jan; 6(1):45-53. PubMed ID: 27790867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma.
    Cui J; Wang N; Zhao H; Jin H; Wang G; Niu C; Terunuma H; He H; Li W
    Int J Cancer; 2014 Jan; 134(2):342-51. PubMed ID: 23825037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular immunotherapy as maintenance therapy prolongs the survival of the patients with small cell lung cancer.
    Ding X; Cao H; Chen X; Jin H; Liu Z; Wang G; Cai L; Li D; Niu C; Tian H; Yang L; Zhao Y; Li W; Cui J
    J Transl Med; 2015 May; 13():158. PubMed ID: 25968637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of chemotherapy combined with cytokine-induced killer cell /dendritic cell-cytokine-induced killer cell therapy for treatment of gastric cancer in China: A systematic review and meta-analysis.
    Mu Y; Zhou CH; Chen SF; Ding J; Zhang YX; Yang YP; Wang WH
    Cytotherapy; 2016 Sep; 18(9):1162-77. PubMed ID: 27421742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy with cytokine-induced killer cells as an adjuvant treatment for advanced gastric carcinoma: a retrospective study of 165 patients.
    Zhao H; Fan Y; Li H; Yu J; Liu L; Cao S; Ren B; Yan F; Ren X
    Cancer Biother Radiopharm; 2013 May; 28(4):303-9. PubMed ID: 23506427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous Cytokine-Induced Killer Cells Improves Overall Survival of Metastatic Colorectal Cancer Patients: Results From a Phase II Clinical Trial.
    Zhao H; Wang Y; Yu J; Wei F; Cao S; Zhang X; Dong N; Li H; Ren X
    Clin Colorectal Cancer; 2016 Sep; 15(3):228-35. PubMed ID: 27052743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoptive transfer of natural killer cells in combination with chemotherapy improves outcomes of patients with locally advanced colon carcinoma.
    Li L; Li W; Wang C; Yan X; Wang Y; Niu C; Zhang X; Li M; Tian H; Yao C; Jin H; Han F; Xu D; Han W; Li D; Cui J
    Cytotherapy; 2018 Jan; 20(1):134-148. PubMed ID: 29056549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immunotherapy plus chemotherapy ameliorates survival in gastric cancer patients: a meta-analysis.
    Hu G; Zhong K; Wang S; Wang S; Ding Q; Xu F; Chen W; Cheng P; Huang L
    Int J Clin Oncol; 2020 Oct; 25(10):1747-1756. PubMed ID: 32728865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study.
    Qiao G; Wang X; Zhou L; Zhou X; Song Y; Wang S; Zhao L; Morse MA; Hobeika A; Song J; Yi X; Xia X; Ren J; Lyerly HK
    Clin Cancer Res; 2019 Mar; 25(5):1494-1504. PubMed ID: 30514775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic outcomes of combining cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer.
    Yuanying Y; Lizhi N; Feng M; Xiaohua W; Jianying Z; Fei Y; Feng J; Lihua H; Jibing C; Jialiang L; Kecheng X
    Cryobiology; 2013 Oct; 67(2):235-40. PubMed ID: 23948179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy in combination with cytokine-induced killer cell transfusion: An effective therapeutic option for patients with extensive stage small cell lung cancer.
    Huang J; Kan Q; Lan ; Zhao X; Zhang Z; Yang S; Li H; Wang L; Xu L; Cheng Z; Zhang Y
    Int Immunopharmacol; 2017 May; 46():170-177. PubMed ID: 28292730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients.
    Qian L; Wang N; Tian H; Jin H; Zhao H; Niu C; He H; Ge T; Han W; Hu J; Li D; Han F; Xu J; Ding X; Chen J; Li W; Cui J
    J Immunol Res; 2016; 2016():6837241. PubMed ID: 27069936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical activity of adjuvant cytokine-induced killer cell immunotherapy in patients with post-mastectomy triple-negative breast cancer.
    Pan K; Guan XX; Li YQ; Zhao JJ; Li JJ; Qiu HJ; Weng DS; Wang QJ; Liu Q; Huang LX; He J; Chen SP; Ke ML; Zeng YX; Xia JC
    Clin Cancer Res; 2014 Jun; 20(11):3003-11. PubMed ID: 24668644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effects of autologous dendritic cells combined with cytokine-induced killer cells followed by chemotherapy in treating patients with advanced colorectal cancer: a prospective study.
    Lin T; Song C; Chuo DY; Zhang H; Zhao J
    Tumour Biol; 2016 Apr; 37(4):4367-72. PubMed ID: 26499782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous cytokine-induced killer cell therapy in lung cancer patients: a retrospective study.
    Zhang J; Zhu L; Du H; He X; Yin Y; Gu Y; Liu L; Lu K; Guo R; Liu P; Shu Y
    Biomed Pharmacother; 2015 Mar; 70():248-52. PubMed ID: 25776508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.
    Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2607-2618. PubMed ID: 28871458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor MICA status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer.
    Chen Y; Lin WS; Zhu WF; Lin J; Zhou ZF; Huang CZ; Chen G; Shi Y; Guo ZQ; Ye YB
    Immunol Res; 2016 Feb; 64(1):251-9. PubMed ID: 26607264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients.
    Gao D; Li C; Xie X; Zhao P; Wei X; Sun W; Liu HC; Alexandrou AT; Jones J; Zhao R; Li JJ
    PLoS One; 2014; 9(4):e93886. PubMed ID: 24699863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer.
    Shi L; Zhou Q; Wu J; Ji M; Li G; Jiang J; Wu C
    Cancer Immunol Immunother; 2012 Dec; 61(12):2251-9. PubMed ID: 22674056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.